Radiation-Induced Ocular Surface Disorders and Retinopathy: Ocular Structures and Radiation Dose-Volume Effect
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: This study aimed to evaluate the radiation-induced adverse effects on ocular structures in head and neck cancer patients and investigate the radiation dose-volume effects on the cornea, lacrimal gland, retina, optic nerve and chiasm. Materials and methods: A total of 38 eyes of 19 patients were included in this prospective, cohort study. All patients underwent complete ophthalmological examination in addition to contrast sensitivity, visual field and visual evoked potentials (VEP) tests. Ophthalmological examinations and psychophysical tests were performed in 6th, 12th, 18th, 24th months and in the last visit. The relationship between the ophthalmologic findings, and the radiation doses below and above the cut-off values was evaluated. Results: Contrast sensitivity decrease and visual field deterioration were observed in 42% of the patients in the last visit (median 26 months) whereas a prolonged latency and decreased amplitude of P100 wave in VEP was observed in 58% and 33% of the eyes, respectively at 24th month. Totally 16 patients (84.2%) developed dry eye disease and eight of them received radiotherapy below tolerance doses and had mild to moderate dry eye findings. Radiation-induced retinopathy was observed in three of the eyes in eight patients who received radiation above tolerance dose. Conclusion: Head and neck cancers treated with radiotherapy, resulted in various ophthalmic complications. All patients who are treating with radiotherapy should be evaluated by an ophthalmologist in terms of anterior and posterior segment damage, even if the radiation dose is below the tolerance limit.
Abstract
Purpose: This study aimed to evaluate the radiation-induced adverse effects on ocular structures in head and neck cancer patients and investigate the radiation dose-volume effects on the cornea, lacrimal gland, retina, optic nerve and chiasm. Materials and methods: A total of 38 eyes of 19 patients were included in this prospective, cohort study. All patients underwent complete ophthalmological examination in addition to contrast sensitivity, visual field and visual evoked potentials (VEP) tests. Ophthalmological examinations and psychophysical tests were performed in 6th, 12th, 18th, 24th months and in the last visit. The relationship between the ophthalmologic findings, and the radiation doses below and above the cut-off values was evaluated. Results: Contrast sensitivity decrease and visual field deterioration were observed in 42% of the patients in the last visit (median 26 months) whereas a prolonged latency and decreased amplitude of P100 wave in VEP was observed in 58% and 33% of the eyes, respectively at 24th month. Totally 16 patients (84.2%) developed dry eye disease and eight of them received radiotherapy below tolerance doses and had mild to moderate dry eye findings. Radiation-induced retinopathy was observed in three of the eyes in eight patients who received radiation above tolerance dose. Conclusion: Head and neck cancers treated with radiotherapy, resulted in various ophthalmic complications. All patients who are treating with radiotherapy should be evaluated by an ophthalmologist in terms of anterior and posterior segment damage, even if the radiation dose is below the tolerance limit.
참고문헌 (21)
- Archer DB, "Radiation retinopathy : clinical, histopathological, ultrastructural and experimental correlations", Eye(Lond), 5(Pt 2), pp.239~251 (1991)
- Parsons JT, "Radiation retinopathy after external-beam irradiation : analysis of time-dose factors", Int J Radiat Oncol Biol Phys, 30, pp.765~773 (1994)
- Jeganathan VS, "Ocular risks from orbital and periorbital radiation therapy : a critical review", Int J Radiat Oncol Biol Phys, 79, pp.650~659 (2011)
- Brouwer CL, "CT-based delineation of organs at risk in the head and neck region : DAHANCA, EORTC, GORTEC, HKNPCSG, NCIC CTG, NCRI, NRG Oncology and TROG consensus guidelines", Radiother Oncol, 117, pp.83~90 (2015)
- Sanli O, "Limbal stem cells and their clinical significance", Turkiye Klinikleri J Ophtalmol, 11, pp.227~232 (2002)
- Moss WT, "Radiation oncology", pp.147~155 (1979), C.V. Mosby
- Dua HS, "Stem cell differentiation and the effects of deficiency", Eye(Lond), 17, pp.877~885 (2003)
- Bomford CK, "Walter and Miller’s textbook of radiotherapy", pp.225~244 (2003), Churchill Livingstone
- Karp LA, "Radiation-induced atrophy of the Meibomian gland", Arch Ophthalmol, 97, pp.303~305 (1979)
- Kennerdell JS, "Low-dose radiotherapy for lymphoid lesions of the orbit and ocular adnexa", Ophthalmic Plast Reconstr Surg, 15, pp.129~133 (1999)
- Parsons JT, "Response of the normal eye to high dose radiotherapy", Oncology(Williston Park), 10, pp.837~847 (1996)
- Stafford SL, "Orbital lymphoma : radiotherapy outcome and complications", Radiother Oncol, 59, pp.139~144 (2001)
- Parsons JT, "Severe dry-eye syndrome following external beam irradiation", Int J Radiat Oncol Biol Phys, 30, pp.775~780 (1994)
- Suarez Baraza J, "Proliferative radiation retinopathy", Arch Soc Esp Oftalmol, 78, pp.215~218 (2003)
- Monroe AT, "Preventing radiation retinopathy with hyperfractionation", Int J Radiat Oncol Biol Phys, 61, pp.856~864 (2005)
- Zamber RW, "Radiation retinopathy", West J Med, 157, pp.530~533 (1992)
- Anteby I, "Ocular and orbital complications following the treatment of retinoblastoma", Eur J Ophthalmol, 8, pp.106~111 (1998)
- Gupta A, "Radiation retinopathy : case report and review", BMC Ophthalmol, 7, pp.6~ (2007)
- Durkin SR, "Ophthalmic and adnexal complications of radiotherapy", Acta Ophthalmol Scand, 85, pp.240~250 (2007)
- Lee AW, "International guideline on dose prioritization and acceptance criteria in radiation therapy planning for nasopharyngeal carcinoma", Int J Radiat Oncol Biol Phys, 105, pp.567~580 (2019)
- Ozkaya Akagunduz O, "Evaluation of the radiation dose-volume effects of optic nerves and chiasm by psychophysical, electrophysiologic tests, and optical coherence tomography in nasopharyngeal carcinoma", Technol Cancer Res Treat, 16, pp.969~977 (2017)